Fluxion Biosciences Launches Discovery Services Unit

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, a privately held drug discovery tools and services company, announced today that it is launching a Discovery Services business to support growing demand for assay support on Fluxion’s unique cell analysis platforms. The new unit, supported by expanded technical personnel and resources, enables Fluxion to offer a range of high-value cell assays in ion channels, functional cell analysis, and circulating tumor cell analysis.